Premier Path Wealth Partners, LLC Gilead Sciences, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $777 Billion
- Q3 2025
A detailed history of Premier Path Wealth Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 11,087 shares of GILD stock, worth $1.38 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
11,087
Previous 9,769
13.49%
Holding current value
$1.38 Million
Previous $1.08 Billion
13.62%
% of portfolio
0.16%
Previous 0.15%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,372Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...